- Home
- EVI vs TLSA Comparison
EVI vs TLSA Comparison
Compare EVI & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVI
- TLSA
- Stock Information
- Founded
- EVI 1959
- TLSA 2013
- Country
- EVI United States
- TLSA United Kingdom
- Employees
- EVI N/A
- TLSA N/A
- Industry
- EVI Other Consumer Services
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- EVI Consumer Discretionary
- TLSA Health Care
- Exchange
- EVI Nasdaq
- TLSA Nasdaq
- Market Cap
- EVI 198.5M
- TLSA 175.3M
- IPO Year
- EVI N/A
- TLSA 2000
- Fundamental
- Price
- EVI $18.54
- TLSA $1.36
- Analyst Decision
- EVI
- TLSA
- Analyst Count
- EVI 0
- TLSA 0
- Target Price
- EVI N/A
- TLSA N/A
- AVG Volume (30 Days)
- EVI 11.1K
- TLSA 475.2K
- Earning Date
- EVI 05-12-2025
- TLSA 06-10-2025
- Dividend Yield
- EVI 1.67%
- TLSA N/A
- EPS Growth
- EVI 29.85
- TLSA N/A
- EPS
- EVI 0.48
- TLSA N/A
- Revenue
- EVI $370,020,000.00
- TLSA N/A
- Revenue This Year
- EVI N/A
- TLSA N/A
- Revenue Next Year
- EVI N/A
- TLSA N/A
- P/E Ratio
- EVI $38.61
- TLSA N/A
- Revenue Growth
- EVI 3.51
- TLSA N/A
- 52 Week Low
- EVI $14.51
- TLSA $0.63
- 52 Week High
- EVI $21.81
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- EVI 57.34
- TLSA 49.87
- Support Level
- EVI $17.56
- TLSA $1.30
- Resistance Level
- EVI $18.90
- TLSA $1.68
- Average True Range (ATR)
- EVI 0.74
- TLSA 0.16
- MACD
- EVI 0.10
- TLSA -0.03
- Stochastic Oscillator
- EVI 88.20
- TLSA 17.50
About EVI EVI Industries Inc.
EVI Industries Inc through its subsidiaries, is a distributor that sells, leases, and rents commercial, industrial, and vended laundry and dry cleaning equipment and steam and hot water boilers manufactured by others, supplies related replacement parts and accessories, designs and plans turn-key laundry, dry cleaning, and boiler systems, and provides installation and maintenance services to its customers, which include commercial, industrial, institutional, government, and retail customers. These activities are conducted in the United States, Canada, the Caribbean, and Latin America.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.